<h4>IPAP Post-Traumatic Stress Disorder (PTSD) Algorithm Faculty</h4>

<b>Jonathan R.T. Davidson, MD</b>
<p>
Speaker for Solvay Pharmaceuticals, Pfizer Inc., GlaxoSmithKline, Wyeth Pharmaceuticals, Lichtwer Pharma,  Forest, American Psychiatric Association</p>
<p>
Research Support  from Pfizer, Solvay, Eli Lilly, GlaxoSmithKline, Wyeth, Organon Inc., Forest, PureWorld, Allergan, Nutrition 21, Bristol Myers Squibb, Johnson and Johnson, Cephalon, Astra Zeneca, Parke Davis, Pharmacia, Upjohn, UCB, Merck, Janssen</p>
<p>
Advisory Board  for Solvay, Pfizer, GlaxoSmithKline, Forest,  Eli Lilly, Ancile, Roche, MediciNova, Jazz, Novartis, Organon, Boehringer Ingelheim, MedTap, Research Triangle Institute, Astra Zeneca, Johnson and Johnson, Wyeth, Bristol Myers Squibb, Boots, UCB, Sanofi-Synthelabo, Alexza, Janssen</p>
<p>
Drugs Supplied for Other Studies from Eli Lilly,  Schwabe, PureWorld, Pfizer Inc.</p>
<p>
Royalties from MultiHealth Systems Inc, Guilford Publications, American Psychiatric Association, Penguin Putnam Publishers, Current Medical Science, Martin Dunitz, Taylor and Francis.</p>
<b>Ken Jobson</b>
<p>
None Applicable</p>
<b>Dan Stein</b>
<p>
Dr.  Stein has received research grants and/or consultancy honoraria from Astrazeneca, Eli-Lilly, GlaxoSmithKline, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, and Wyeth.</p>
<b>Kathryn Connor</b>
<p>
Grants and Research Support:  Eli Lilly; Pfizer, Inc., Pure World Botanicals, Inc.; Forest Laboratories, Inc; Glaxo SmithKline</p>
<p>
Speakers Bureau:  Ortho McNeil, Inc.; Pfizer, Inc.; Wyeth Ayerst Pharmaceutical Company; Cephalon Pharmaceuticals, Inc.; Solvay Pharmaceuticals; Forest Laboratories, Inc.</p>
<p>
Consultant:  Ortho McNeil, Inc.; Pfizer, Inc.;  Schwarz Pharma Inc;  King Pharmaceuticals; Cephalon Pharmaceuticals, Inc.; Predix Pharmaceuticals;  Jazz Pharmaceuticals</p>
<p>
Other Financial or Material Support:   Dr. Wilmar Schwabe; Nutrition 21; Cephalon, Inc.;   Nordic Naturals, Inc.; Solvay Pharmaceuticals</p>
<p>
<b>Marcio Bernik</b>
<p>
Dr. Bernik has in the past 4 years received research grants from FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo) and drug companies: Roche, Whyeth and Glaxo Wellcome. Dr. Bernik has been in the last 4 years in the adviser/speaker boards for Roche, Novartis, Pfizer and Wyeth.</p>
<b>Matthew Friedman</b>
<p>
During the past 2 years I have received honoraria for lectures or consultation from AstraZenica, Shire, Ortho-McNeil and GlaxoSmithKline</p>
<b>Yoshiharu Kim</b>
<p>
I am the chairman of the clinical trial of paroxetine for PTSD in Japan, which is still ongoing.  I do not personally receive any financial aid from the Glaxo Smith Klein.</p>
<b>Yves Lecrubier</b>
<p>
Advisory boards, consulting, sponsored trials: Sanofi, Eli Lilly, Novartis, P. Fabre, Merck, Janssen, Wyeth Pederle, Lundbeck</p>
<p>
Stock holding: No</p>
<b>Hong Mah</b>
<p>
TBD</p>
<b>Frank Njenga</b>
<p>
TBD</p>
<b>Joseph Zohar</b>
<p>
Prof. Zohar has received research funding from Pfizer and Lundbeck.</p>
<p>
He has lectured for Wyeth, Solvay and Pfizer.</p>
<p>